Myhibbin
Active Ingredient(s): Mycophenolate MofetilFDA Approved: * May 1, 2024
Pharm Company: * AZURITY
Category: Immunosuppressive
Mycophenolic acid (MPA) is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus.[9][10] Specifically it is used following kidney, heart, and liver transplantation.[10] It can be given by mouth or by injection into a vein.[10] It comes as mycophenolate sodium and mycophenolate mofetil.[10] Common side effects i... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.